![Hans-Peter Gerber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hans-Peter Gerber
Hoofd Techniek/Wetenschap/O&O bij
SUTRO BIOPHARMA, INC.
Vermogen: 324 298 $ op 30-06-2026
Profiel
Hans-Peter Gerber currently works at T-CURX GmbH, as Chairman and Sutro Biopharma, Inc., as Chief Scientific Officer from 2023.
Dr. Gerber also formerly worked at NBE-Therapeutics AG, as Independent Director from 2017 to 2021 and Maverick Therapeutics, Inc., as President, Director & Chief Science Officer from 2016 to 2018.
Dr. Gerber received his graduate degree and doctorate degree from the University of Zurich.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 9.768 ( 0,06% ) | 324 298 $ | 30-06-2026 |
Actieve functies van Hans-Peter Gerber
| Bedrijven | Functie | Begin |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Hoofd Techniek/Wetenschap/O&O | 18-09-2023 |
T-CURX GmbH
 T-CURX GmbH BiotechnologyHealth Technology Operates as a biotech company that develops immunotherapies to treat cancer | Voorzitter | - |
Eerdere bekende functies van Hans-Peter Gerber
| Bedrijven | Functie | Einde |
|---|---|---|
NBE-Therapeutics AG
 NBE-Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops antibody drug conjugates and advancing targeted cancer therapies | Directeur/Bestuurslid | 01-01-2021 |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | President | 01-01-2018 |
Opleiding van Hans-Peter Gerber
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
42
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
University of Zurich
 University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NBE-Therapeutics AG
NBE-Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops antibody drug conjugates and advancing targeted cancer therapies | Health Technology |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | Health Technology |
T-CURX GmbH
T-CURX GmbH BiotechnologyHealth Technology Operates as a biotech company that develops immunotherapies to treat cancer | Health Technology |
